Temporarily Closed. New orders are paused while we resolve an unforeseen operational issue. Existing orders will still be fulfilled.

Glow

Accelerating

glow appears in 1,527 indexed publications going back to 1982, including 99 in the past twelve months. 21 registered trials appear on ClinicalTrials.gov.

1,527
Indexed publications
99
Past 12 months, against 48 the year before
21
Registered clinical trials
549
Monthly readers on Wikipedia, down 12%

On This Figure
Glow is a blend. These figures combine its components (GHK-Cu, BPC-157, TB-500), so totals are an upper bound where a single paper covers more than one of them.

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20152
20163
20171
20183
20193
20209
20214
20223
202312
20246
202511
202628
Public Attention

Who is looking it up

Monthly readers of the Glow article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-092026-08
Clinical Trials

The registered pipeline

Early Phase 1
0
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Phase distribution across the most recently updated registered trials.

References

Most recent work

The newest indexed records mentioning Glow, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

  1. 2026-09-09·Advanced healthcare materials

    Water-Soluble, Enzyme-Degradable, and Hydrolyzable STAR Particles for Enhanced Drug Delivery to Skin

    Sadeqi A, Arslan Azizoğlu G, Prausnitz MR. et al.

  2. 2026-08-29·Applied biochemistry and biotechnology

    Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis

    Zhang H, Shao L, Feng Q et al.

  3. 2026-08-24·Current pain and headache reports

    Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management

    Luansritisakul C, Chiang MC, Burns SL et al.

  4. 2026-08-20·Aesthetic surgery journal

    The Regenerative Potential of GHK-Cu in Aesthetic Medicine

    Mokhtar J, Mohamad B, Haddad J et al.

  5. 2026-08-17·Molecular biomedicine

    Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling

    Zhao TR, Hu EB, Wang MW et al.

  6. 2026-08-11·The American journal of sports medicine

    Peptide Supplements and Their Therapeutic Applications in Sports Medicine

    Tewari K, Liu TP, Im C et al.

  7. 2026-08-01·Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

    Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu

    Wang J, Tao K, Huang H et al.

  8. 2026-08-01·Clinical science (London, England : 1979)

    Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway

    Ouyang X, Long Z, Xu X et al.

In the Catalogue

Glow available from Polaris Research

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-09-13.